Ocuphire Pharma Investor Presentation Deck
Management Team with Decades of Drug Development Experience
MGI.
PHARMA
Richard Rodgers, MBA
Interim CEO
CARLSON
SCHOOL OF MANAGEMENT
UNIVERSITY OF MINNESOTA
TESARO™
Abraxis
BioScience
SIRION
Therapeutics
Bindu Manne
Head, Market Development
and Commercialization
Takeda
UNC Shire
PEMBROKE
ThromboGenics®
III
MERCK Ocular equinox
Therapeutix
FLORIDA TECH
BETALIO Revitalid
POINT GUARD
PARTNERS LLC
Drey Coleman
VP, Clinical Operations
OCULOS
Integrated Insight.
Ronil Patel, MTech, MS
SVP, Operations and BD
UCF
aerpio
OCULOS
Integrated Insight.
Chris Ernst
Global Head, QA
and Manufacturing
NORTHERN
KENTUCKY
Akebia
THERAPEUTICS
MEDPACE
Charlie Hoffmann, MBA
SVP, Corporate Development
Tuck School of Business
IIIII at Dartmouth
TOOO
Prudential
Syber Goldman
DevEx
Sachs
Ocularis Pharma
Mitch Brigell, PhD
Head, Clinical Development
and Strategy
KANSAS STATE
aerpio
& NOVARTIS
UNIVERSITY
Pfizer
aerpio
Laura Gambino
Director, Project Management
EASTERN
MICHIGAN UNIVERSITY
THERAPEUTICS
GE
aerpio SUBC
Pfizer
MIMICHIGAN ROSS
Pfizer
Barbara Withers, PhD
VP, Clinical and
Regulatory Strategy
Amy Rabourn, CPA
SVP, Finance
Therapeutics
NeuroBo
PHARMACEUTICALS
WAYNE STATE
UNIVERSITY
SCHOOL OF MEDICINE
Pfizer
pwc
Daniela Oniciu, PhD
Global Head, R&D, Chemistry
and Product Development
UNIVERSITY of
UF
Gemphire
Cerenis™ Pfizer
THERAPEUTICS
ESPERION®
40View entire presentation